Jul 15, 2015
European regulators--under the influence of industry-backed research--are on the cusp of re-approving the use of the Roundup chemical glysophate, reporting Wednesday revealed, despite the fact that the World Health Organization recently deemed the widely-used herbicide a probable carcinogen.
An imminent decision by the European Food Safety Authority will determine whether glysophate, a main ingredient in Monsanto's Roundup and Dow's Enlist Duo, will be permitted on the continent. Sources from within the agency told the Guardian that findings by the WHO research group, the International Agency for Research on Cancer (IARC), may delay the approval.
However, documents obtained by the newspaper show that a key assessment by the German Federal Institute for Risk Assessments (BfR), sourcing information from agrochemical industry research, "has drawn contrary conclusions from the IARC's data."
The Guardian reports that the BfR paper "relied heavily on unpublished papers provided by the Glyphosate Task Force, an industry body dedicated to the herbicide's relicensing," whose website is run by Monsanto UK.
Further, the report found "very limited evidence of carcinogenicity" in mice exposed to the chemical, and recommended its re-approval calling for an even further relaxed "acceptable daily intake from 0.3 to 0.5 mg per kilogram of bodyweight per day."
Since a Monsanto chemist discovered the herbicide in the 1970s, its use has exploded. The development of glysophate-resistant genetically modified corn and soybean seeds only further hastened its spread.
In Europe, the Guardian notes, "The weedkiller is so widely-used that residues are commonly found in British bread. One survey found that people in 18 EU countries had traces of the weedkiller in their urine."
When asked about the potential re-approval of the toxic herbicide, Greenpeace spokesperson Franziska Achterberg told the Guardian that "Regulators should stop playing Russian roulette with people's health."
Join Us: News for people demanding a better world
Common Dreams is powered by optimists who believe in the power of informed and engaged citizens to ignite and enact change to make the world a better place. We're hundreds of thousands strong, but every single supporter makes the difference. Your contribution supports this bold media model—free, independent, and dedicated to reporting the facts every day. Stand with us in the fight for economic equality, social justice, human rights, and a more sustainable future. As a people-powered nonprofit news outlet, we cover the issues the corporate media never will. |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Lauren McCauley
Lauren McCauley is a former senior editor for Common Dreams covering national and international politics and progressive news. She is now the Editor of Maine Morning Star. Lauren also helped produce a number of documentary films, including the award-winning Soundtrack for a Revolution and The Hollywood Complex, as well as one currently in production about civil rights icon James Meredith. Her writing has been featured on Newsweek, BillMoyers.com, TruthDig, Truthout, In These Times, and Extra! the newsletter of Fairness and Accuracy in Reporting. She currently lives in Kennebunk, Maine with her husband, two children, a dog, and several chickens.
European regulators--under the influence of industry-backed research--are on the cusp of re-approving the use of the Roundup chemical glysophate, reporting Wednesday revealed, despite the fact that the World Health Organization recently deemed the widely-used herbicide a probable carcinogen.
An imminent decision by the European Food Safety Authority will determine whether glysophate, a main ingredient in Monsanto's Roundup and Dow's Enlist Duo, will be permitted on the continent. Sources from within the agency told the Guardian that findings by the WHO research group, the International Agency for Research on Cancer (IARC), may delay the approval.
However, documents obtained by the newspaper show that a key assessment by the German Federal Institute for Risk Assessments (BfR), sourcing information from agrochemical industry research, "has drawn contrary conclusions from the IARC's data."
The Guardian reports that the BfR paper "relied heavily on unpublished papers provided by the Glyphosate Task Force, an industry body dedicated to the herbicide's relicensing," whose website is run by Monsanto UK.
Further, the report found "very limited evidence of carcinogenicity" in mice exposed to the chemical, and recommended its re-approval calling for an even further relaxed "acceptable daily intake from 0.3 to 0.5 mg per kilogram of bodyweight per day."
Since a Monsanto chemist discovered the herbicide in the 1970s, its use has exploded. The development of glysophate-resistant genetically modified corn and soybean seeds only further hastened its spread.
In Europe, the Guardian notes, "The weedkiller is so widely-used that residues are commonly found in British bread. One survey found that people in 18 EU countries had traces of the weedkiller in their urine."
When asked about the potential re-approval of the toxic herbicide, Greenpeace spokesperson Franziska Achterberg told the Guardian that "Regulators should stop playing Russian roulette with people's health."
Lauren McCauley
Lauren McCauley is a former senior editor for Common Dreams covering national and international politics and progressive news. She is now the Editor of Maine Morning Star. Lauren also helped produce a number of documentary films, including the award-winning Soundtrack for a Revolution and The Hollywood Complex, as well as one currently in production about civil rights icon James Meredith. Her writing has been featured on Newsweek, BillMoyers.com, TruthDig, Truthout, In These Times, and Extra! the newsletter of Fairness and Accuracy in Reporting. She currently lives in Kennebunk, Maine with her husband, two children, a dog, and several chickens.
European regulators--under the influence of industry-backed research--are on the cusp of re-approving the use of the Roundup chemical glysophate, reporting Wednesday revealed, despite the fact that the World Health Organization recently deemed the widely-used herbicide a probable carcinogen.
An imminent decision by the European Food Safety Authority will determine whether glysophate, a main ingredient in Monsanto's Roundup and Dow's Enlist Duo, will be permitted on the continent. Sources from within the agency told the Guardian that findings by the WHO research group, the International Agency for Research on Cancer (IARC), may delay the approval.
However, documents obtained by the newspaper show that a key assessment by the German Federal Institute for Risk Assessments (BfR), sourcing information from agrochemical industry research, "has drawn contrary conclusions from the IARC's data."
The Guardian reports that the BfR paper "relied heavily on unpublished papers provided by the Glyphosate Task Force, an industry body dedicated to the herbicide's relicensing," whose website is run by Monsanto UK.
Further, the report found "very limited evidence of carcinogenicity" in mice exposed to the chemical, and recommended its re-approval calling for an even further relaxed "acceptable daily intake from 0.3 to 0.5 mg per kilogram of bodyweight per day."
Since a Monsanto chemist discovered the herbicide in the 1970s, its use has exploded. The development of glysophate-resistant genetically modified corn and soybean seeds only further hastened its spread.
In Europe, the Guardian notes, "The weedkiller is so widely-used that residues are commonly found in British bread. One survey found that people in 18 EU countries had traces of the weedkiller in their urine."
When asked about the potential re-approval of the toxic herbicide, Greenpeace spokesperson Franziska Achterberg told the Guardian that "Regulators should stop playing Russian roulette with people's health."
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.